[Narcolepsy--new implications of molecular biology]

Ugeskr Laeger. 2006 Oct 23;168(43):3699-704.
[Article in Danish]

Abstract

Narcolepsy is a common but underdiagnosed sleep disorder characterized by excessive daytime sleepiness and abnormal manifestations of REM sleep: cataplexy, sleep paralysis and hypnagogogic hallucinations. Sleep onset REM periods (SOREMPs) are diagnostic. Within the last five years the pathogenesis has become clearer: narcolepsy is associated with almost total absence of the neuropeptides hypocretin-1 and -2 in the hypothalamus and CSF. A low level of CSF hypocretin is now recognized as a new diagnostic tool. This review provides updated knowledge of narcolepsy.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Biomarkers / cerebrospinal fluid
  • Diagnosis, Differential
  • Female
  • Humans
  • Intracellular Signaling Peptides and Proteins / cerebrospinal fluid
  • Male
  • Narcolepsy* / cerebrospinal fluid
  • Narcolepsy* / diagnosis
  • Narcolepsy* / drug therapy
  • Narcolepsy* / physiopathology
  • Neuropeptides / cerebrospinal fluid
  • Orexins
  • Polysomnography
  • Risk Factors
  • Sleep, REM / physiology

Substances

  • Biomarkers
  • HCRT protein, human
  • Intracellular Signaling Peptides and Proteins
  • Neuropeptides
  • Orexins